Bristol-Myers Squibb Co (NYSE:BMY) has a beta value of 0.38 and has seen 2.32 million shares traded in the recent trading session. The company, currently valued at $97.29B, closed the recent trade at $47.81 per share which meant it gained $0.95 on the day or 2.02% during that session. The BMY stock price is -32.46% off its 52-week high price of $63.33 and 16.5% above the 52-week low of $39.92. If we look at the company’s 10-day average daily trading volume, we find that it stood at 14.07 million shares traded. The 3-month trading volume is 14.96 million shares.
The consensus among analysts is that Bristol-Myers Squibb Co (BMY) is Hold stock at the moment, with a recommendation rating of 2.64. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 9 out of 14 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight.
Bristol-Myers Squibb Co (NYSE:BMY) trade information
Sporting 2.02% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BMY stock price touched $47.81 or saw a rise of 1.65%. Year-to-date, Bristol-Myers Squibb Co shares have moved 16.26%, while the 5-day performance has seen it change 2.83%. Over the past 30 days, the shares of Bristol-Myers Squibb Co (NYSE:BMY) have changed -4.69%. Short interest in the company has seen 33.61 million shares shorted with days to cover at 2.58.
Wall Street analysts have a consensus price target for the stock at $66.5, which means that the shares’ value could jump 28.11% from the levels at last check today.. The projected low price target is $65.0 while the price target rests at a high of $68.0. In that case, then, we find that the latest price level in today’s session is -42.23% off the targeted high while a plunge would see the stock gain -35.95% from the levels at last check today..
Bristol-Myers Squibb Co (BMY) estimates and forecasts
The company’s shares have lost -15.85% over the past 6 months.
Earnings growth for 2025 is a modest 483.33% while over the next 5 years, the company’s earnings are expected to increase by 72.29%.
BMY Dividends
Bristol-Myers Squibb Co is expected to release its next earnings report on 2025-Apr-24 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 2.46 at a share yield of 5.15%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 3.63%.
Bristol-Myers Squibb Co (NYSE:BMY)’s Major holders
Insiders own 0.07% of the company shares, while shares held by institutions stand at 82.11% with a share float percentage of 82.17%. Investors are also buoyed by the number of investors in a company, with Bristol-Myers Squibb Co having a total of 3132.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 186.57 million shares worth more than $7.75 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.2043% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 158.66 million shares as of 2024-06-30. The firm’s total holdings are worth over $6.59 billion and represent 7.8273% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.15% shares in the company for having 64.1 shares of worth $3.06 billion while later fund manager owns 56.39 shares of worth $2.69 billion as of Mar 31, 2025 , which makes it owner of about 2.77% of company’s outstanding stock.
